|
US20050119251A1
(en)
*
|
2001-12-21 |
2005-06-02 |
Jian-Min Fu |
Nicotinamide derivatives and their use as therapeutic agents
|
|
DE10217006A1
(de)
*
|
2002-04-16 |
2003-11-06 |
Merck Patent Gmbh |
Substituierte Indole
|
|
DE10259244A1
(de)
*
|
2002-12-17 |
2004-07-01 |
Merck Patent Gmbh |
N-(Indolethyl-)cycloamin-Verbindungen
|
|
ES2280824T3
(es)
*
|
2002-12-20 |
2007-09-16 |
Merck Patent Gmbh |
Benzodioxepinas substituidas.
|
|
AU2004303461B2
(en)
*
|
2003-12-23 |
2011-04-28 |
H. Lundbeck A/S |
2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
|
|
AR052308A1
(es)
*
|
2004-07-16 |
2007-03-14 |
Lundbeck & Co As H |
Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
|
|
EP2400300A1
(en)
|
2004-08-25 |
2011-12-28 |
Takeda Pharmaceutical Company Limited |
Method of screening preventives/remedies for stress urinary incontinence
|
|
BRPI0515477A
(pt)
*
|
2004-09-20 |
2008-07-22 |
Xenon Pharmaceuticals Inc |
derivados heterocìclicos bicìclicos e o uso dos mesmos como inibidores de estaroil-coa-desaturase (scd)
|
|
AR051026A1
(es)
|
2004-09-20 |
2006-12-13 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
|
|
WO2006101521A2
(en)
|
2004-09-20 |
2006-09-28 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
US7951805B2
(en)
|
2004-09-20 |
2011-05-31 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
US8071603B2
(en)
|
2004-09-20 |
2011-12-06 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
AU2005286846A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
|
EP2316458A1
(en)
|
2004-09-20 |
2011-05-04 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
|
TW200630337A
(en)
*
|
2004-10-14 |
2006-09-01 |
Euro Celtique Sa |
Piperidinyl compounds and the use thereof
|
|
DE602005022113D1
(de)
*
|
2005-01-07 |
2010-08-12 |
Hoffmann La Roche |
Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
|
|
DE102005019670A1
(de)
*
|
2005-04-26 |
2006-11-02 |
Merck Patent Gmbh |
Verfahren zur Herstellung von (5-(4-[4-(5-Cyano-3-indolyl)-butyl)-1-piperazinyl)-benzofuran-2-carboxamid
|
|
JP2009513563A
(ja)
*
|
2005-06-03 |
2009-04-02 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
ヒトのステアロイル−ＣｏＡデサチュラーゼ阻害剤としてのアミノチアゾール誘導体
|
|
TW200800959A
(en)
*
|
2005-06-10 |
2008-01-01 |
Wyeth Corp |
Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
|
|
MX2007015772A
(es)
|
2005-06-17 |
2008-02-22 |
Wyeth Corp |
Compuestos utiles como inhibidores de serotonina y agonistas y antagonistas de 5-ht-1a.
|
|
AR054393A1
(es)
*
|
2005-06-17 |
2007-06-20 |
Lundbeck & Co As H |
Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
|
|
US7629473B2
(en)
*
|
2005-06-17 |
2009-12-08 |
H. Lundbeck A/S |
2-(1H-indolylsulfanyl)-aryl amine derivatives
|
|
WO2007007910A1
(ja)
*
|
2005-07-13 |
2007-01-18 |
Banyu Pharmaceutical Co., Ltd. |
ヘテロ環置換ベンズイミダゾール誘導体
|
|
RU2008127501A
(ru)
*
|
2006-01-13 |
2010-02-20 |
Вайет (Us) |
Сульфонилзамещенные 1н-индолы в качастве лигандов 5-гидрокситриптаминовых рецепторов
|
|
US8247442B2
(en)
*
|
2006-03-29 |
2012-08-21 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and their use
|
|
US8791264B2
(en)
*
|
2006-04-13 |
2014-07-29 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and their use as blockers of calcium channels
|
|
WO2007118854A1
(en)
*
|
2006-04-13 |
2007-10-25 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and the use thereof
|
|
WO2007132841A1
(ja)
|
2006-05-16 |
2007-11-22 |
Takeda Pharmaceutical Company Limited |
縮合複素環化合物およびその用途
|
|
WO2008015516A1
(en)
*
|
2006-07-28 |
2008-02-07 |
Pfizer Products Inc. |
Fused tricyclic heterocycles for the treatment of schizophrenia
|
|
US8399486B2
(en)
|
2007-04-09 |
2013-03-19 |
Purdue Pharma L.P. |
Benzenesulfonyl compounds and the use thereof
|
|
JP2010527915A
(ja)
*
|
2007-04-26 |
2010-08-19 |
アバロン ファーマシューティカルズ，インコーポレイテッド |
多重環化合物及びその用途
|
|
EP2178842A2
(en)
|
2007-08-22 |
2010-04-28 |
Abbott GmbH & Co. KG |
4-benzylaminoquinolines, pharmaceutical compositions containing them and their use
|
|
WO2009040659A2
(en)
*
|
2007-09-28 |
2009-04-02 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|
|
JP5520051B2
(ja)
|
2007-11-15 |
2014-06-11 |
武田薬品工業株式会社 |
縮合ピリジン誘導体およびその用途
|
|
AU2009212259A1
(en)
|
2008-02-07 |
2009-08-13 |
Abbott Laboratories |
Amide derivatives as positive allosteric modulators and methods of use thereof
|
|
EP2527328A1
(en)
*
|
2008-04-01 |
2012-11-28 |
Abbott GmbH & Co. KG |
Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
|
|
GB0813142D0
(en)
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0813144D0
(en)
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|
|
CN102498095A
(zh)
|
2009-02-05 |
2012-06-13 |
国立大学法人京都大学 |
二氢吲哚衍生物
|
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
|
EP2413696A4
(en)
*
|
2009-04-03 |
2012-10-24 |
Sinai School Medicine |
COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
US8912220B2
(en)
*
|
2009-08-10 |
2014-12-16 |
Galenea Pharmaceuticals |
Compounds and methods of use thereof
|
|
TWI535440B
(zh)
*
|
2009-10-26 |
2016-06-01 |
Ｌｇ生命科學有限公司 |
包括吲哚化合物之醫藥組成物
|
|
JPWO2011071136A1
(ja)
|
2009-12-11 |
2013-04-22 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
|
WO2011106039A1
(en)
*
|
2010-02-24 |
2011-09-01 |
Research Triangle Institute |
Arylpiperazone opioid receptor antagonists
|
|
WO2012014127A1
(en)
|
2010-07-30 |
2012-02-02 |
Ranbaxy Laboratories Limited |
5-lipoxygenase inhibitors
|
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
PL395470A1
(pl)
|
2011-06-29 |
2013-01-07 |
Adamed Spólka Z Ograniczona Odpowiedzialnoscia |
Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego
|
|
CN103889968A
(zh)
|
2011-08-05 |
2014-06-25 |
艾伯维德国有限责任两合公司 |
氨基苯并二氢吡喃、氨基苯并二氢噻喃及氨基-1,2,3,4-四氢喹啉衍生物，包含这些化合物的药用组合物，及其在治疗中的用途
|
|
MX2014006004A
(es)
|
2011-11-18 |
2015-04-16 |
Abbvie Deutschland |
Derivados de aminobenzociclohepteno, aminotetralina, aminoindano y fenalcilamina n-sustituidas, composiciones farmaceuticas que los contienen, y su uso en terapia.
|
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
|
AU2014336154A1
(en)
|
2013-10-17 |
2016-04-28 |
AbbVie Deutschland GmbH & Co. KG |
Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
JP2016537323A
(ja)
|
2013-10-17 |
2016-12-01 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
アミノクロマン誘導体、アミノチオクロマン誘導体およびアミノ−１，２，３，４−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用
|
|
US9550754B2
(en)
|
2014-09-11 |
2017-01-24 |
AbbVie Deutschland GmbH & Co. KG |
4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US10633336B2
(en)
|
2014-12-19 |
2020-04-28 |
The Broad Institute, Inc. |
Dopamine D2 receptor ligands
|
|
US10752588B2
(en)
|
2014-12-19 |
2020-08-25 |
The Broad Institute, Inc. |
Dopamine D2 receptor ligands
|
|
EP3597186B1
(en)
|
2015-01-05 |
2021-12-08 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Myc g-quadruplex stabilizing small molecules and their use
|
|
CA3077383A1
(en)
|
2017-09-29 |
2019-04-04 |
Sunshine Lake Pharma Co., Ltd. |
Substituted pyrimidine piperazine compound and use thereof
|
|
US20210052600A1
(en)
|
2017-12-27 |
2021-02-25 |
Takeda Pharmaceutical Company Limited |
Therapeutic agents for stress urinary incontinence and incotinence of feces
|
|
CN112851641B
(zh)
*
|
2019-11-28 |
2023-08-15 |
广东东阳光药业股份有限公司 |
嘧啶苯甲酰胺化合物的盐酸盐及其用途
|